PI
SRPT icon

PEAK6 Investments’s Sarepta Therapeutics SRPT Stock Holding History

PEAK6 Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.68M Sell
29,500
-5,300
-15% -$733K 0.01% 1127
2024
Q2 		$5.5M Sell
34,800
-6,000
-15% -$771K 0.01% 796
2024
Q1 		$5.28M Sell
40,800
-16,400
-29% -$2.01M 0.01% 799
2023
Q4 		$5.52M Buy
57,200
+29,000
+103% +$2.78M 0.02% 771
2023
Q3 		$3.42M Buy
28,200
+21,800
+341% +$2.46M 0.02% 963
2023
Q2 		$733K Sell
6,400
-3,600
-36% -$464K ﹤0.01% 1918
2023
Q1 		$1.38M Buy
10,000
+3,400
+52% +$441K 0.01% 1596
2022
Q4 		$855K Sell
6,600
-15,300
-70% -$1.77M ﹤0.01% 2060
2022
Q3 		$2.42M Buy
21,900
+200
+0.9% +$20.2K 0.01% 1390
2022
Q2 		$1.88M Buy
+21,700
New +$1.6M ﹤0.01% 2382
2021
Q1 		– Sell
-3,900
Closed -$665K – 5498
2020
Q4 		$665K Hold
3,900
– – ﹤0.01% 2834
2020
Q3 		$548K Hold
3,900
– – ﹤0.01% 2780
2020
Q2 		$625K Hold
3,900
– – ﹤0.01% 2488
2020
Q1 		$381K Sell
3,900
-56,500
-94% -$6.46M ﹤0.01% 2305
2019
Q4 		$7.79M Buy
60,400
+9,900
+20% +$999K 0.04% 444
2019
Q3 		$3.8M Buy
50,500
+25,100
+99% +$2.96M 0.02% 852
2019
Q2 		$3.86M Sell
25,400
-2,000
-7% -$243K 0.03% 853
2019
Q1 		$3.27M Buy
27,400
+7,400
+37% +$951K 0.02% 962
2018
Q4 		$2.18M Buy
+20,000
New +$2.5M 0.01% 1184

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PEAK6 Investments's SRPT Position: Q3 2023 in Review

PEAK6 Investments sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 5,094 shares — an estimated $576K sold.

PEAK6 Investments first reported a position in SRPT in Q1 2019 and held it in 10 quarters. The position peaked at $3.23M in Q4 2019. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • PEAK6 Investments reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,094 Sarepta Therapeutics shares in Q3 2023, an estimated $576K.
  • PEAK6 Investments first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 10 quarters.
  • PEAK6 Investments's Sarepta Therapeutics position peaked at $3.23M in Q4 2019.
  • 394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.